Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A pore-forming protein with a protease-activated trigger

B Walker1, H Bayley

  • 1Worcester Foundation for Experimental Biology, Shrewsbury, MA 01545.

Protein Engineering
|January 1, 1994
PubMed
Summary

Staphylococcus aureus alpha-hemolysin (alpha HL) mutants were engineered for protease-activated pore formation. These novel alpha HL variants show potential for targeted drug delivery in immunotoxins.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Innovation and enculturation in child communication: a cross-sectional study.

Evolutionary human sciences·2023
Same author

Adult Asthma Diagnosis: Physician Reported Challenges in Alberta-Based Primary Care Practices.

SAGE open nursing·2021
Same author

Treatment, outcomes and costs of asthma exacerbations in Chilean children: a prospective multicenter observational study.

Allergologia et immunopathologia·2019
Same author

Hospitalizations for asthma exacerbation in Chilean children: A multicenter observational study.

Allergologia et immunopathologia·2018
Same author

Work productivity loss in mild to moderate COPD: lessons learned from the CanCOLD study.

The European respiratory journal·2017
Same author

Chronic Administration of Anacetrapib Is Associated With Accumulation in Adipose and Slow Elimination.

Clinical pharmacology and therapeutics·2017

Area of Science:

  • Microbiology
  • Biochemistry
  • Molecular Biology

Background:

  • alpha-Hemolysin (alpha HL) is a pore-forming toxin from Staphylococcus aureus that damages cell membranes.
  • alpha HL activity is linked to specific structural modifications, particularly nicks in its glycine-rich loop.

Purpose of the Study:

  • To design and create novel alpha HL mutants activated by proteases.
  • To investigate the potential of these engineered toxins for targeted applications, such as in immunotoxins.

Main Methods:

  • Engineering of alpha HL overlap mutants with specific protease-sensitive sites.
  • Mutagenesis to control protease recognition and activation specificity.
  • Assessing pore-forming activity and hemolytic function of engineered mutants.

Main Results:

  • Overlap mutants were designed to be activated by protease-mediated removal of redundant amino acids.
  • The specificity of protease activation can be precisely controlled through additional mutagenesis.
  • These findings lay the groundwork for developing protease-activated alpha HL variants.

Conclusions:

  • Engineered alpha HL mutants can be activated by proteases, offering a mechanism for controlled toxin function.
  • The ability to specify the activating enzyme opens possibilities for targeted therapeutic strategies.
  • alpha HL mutants activated by tumor-associated proteases may serve as valuable components in immunotoxin development.

Related Experiment Videos